INSM
Insmed Inc

2,993
Mkt Cap
$34.43B
Volume
3.68M
52W High
$212.75
52W Low
$60.40
PE Ratio
-26.12
INSM Fundamentals
Price
$161.40
Prev Close
$159.27
Open
$160.35
50D MA
$187.95
Beta
0.80
Avg. Volume
3.6M
EPS (Annual)
-$5.57
P/B
36.29
Rev/Employee
$286,158.14
Loading...
Loading...
News
all
press releases
Insmed, Inc. (NASDAQ:INSM) Short Interest Up 23.4% in December
Insmed, Inc. (NASDAQ:INSM - Get Free Report) was the recipient of a significant growth in short interest in the month of December. As of December 31st, there was short interest totaling 11,015,687...
MarketBeat·21h ago
News Placeholder
More News
News Placeholder
Oak Ridge Investments LLC Sells 12,052 Shares of Insmed, Inc. $INSM
Oak Ridge Investments LLC cut its holdings in shares of Insmed, Inc. (NASDAQ:INSM - Free Report) by 35.3% during the 3rd quarter, according to the company in its most recent filing with the...
MarketBeat·2d ago
News Placeholder
Campbell & CO Investment Adviser LLC Invests $2.75 Million in Insmed, Inc. $INSM
Campbell & CO Investment Adviser LLC purchased a new position in Insmed, Inc. (NASDAQ:INSM - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the...
MarketBeat·3d ago
News Placeholder
Insmed, Inc. (NASDAQ:INSM) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Insmed, Inc. (NASDAQ:INSM - Get Free Report) have been given a consensus rating of "Moderate Buy" by the twenty-four analysts that are covering the firm, MarketBeat.com reports. One...
MarketBeat·3d ago
News Placeholder
EULAV Asset Management Acquires Shares of 90,000 Insmed, Inc. $INSM
EULAV Asset Management acquired a new position in shares of Insmed, Inc. (NASDAQ:INSM - Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm acquired...
MarketBeat·4d ago
News Placeholder
Looking At Insmed's Recent Unusual Options Activity
read more...
Benzinga·4d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed...
PR Newswire·5d ago
News Placeholder
Nisa Investment Advisors LLC Acquires 8,261 Shares of Insmed, Inc. $INSM
Nisa Investment Advisors LLC grew its holdings in Insmed, Inc. (NASDAQ:INSM - Free Report) by 374.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange...
MarketBeat·5d ago
News Placeholder
Insmed CEO Will Lewis talks its rare disease drug pipeline
Will Lewis, Insmed CEO, joins 'Fast Money' to talk the rare disease pipeline, acquisitions in the pharma space, and more...
CNBC Television-YouTube·7d ago
News Placeholder
INSM Stock Jumps on 2025 Preliminary Sales, 2026 Goals Announced
Shares of Insmed rise after it tops FY25 sales forecasts, led by strong Brinsupri uptake, and outlines 2026 guidance and pipeline milestones.
Zacks·8d ago
<
1
2
...
>

Latest INSM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.